Chemistry Wealth Management LLC Acquires 4,382 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Chemistry Wealth Management increased its HCA Healthcare stake by 613.7% in the third quarter, purchasing 4,382 additional shares for a total of 5,096 shares valued at $2.175 million.
• Wall Street analysts maintain a “Moderate Buy” consensus on HCA, with 16 Buy, seven Hold, and one Sell rating and an average price target of $467.61.
• HCA reported quarterly revenue of $20.23 billion, up 8.7% year over year, and EPS of $7.59, slightly exceeding estimates. The company also pays a quarterly dividend of $0.78, representing a 0.7% annualized yield.

Chemistry Wealth Management LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 613.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,096 shares of the company's stock after purchasing an additional 4,382 shares during the quarter. Chemistry Wealth Management LLC's holdings in HCA Healthcare were worth $2,175,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. MidFirst Bank purchased a new stake in HCA Healthcare during the 2nd quarter worth approximately $28,000. Clearstead Trust LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $29,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth approximately $33,000. Delos Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the second quarter worth $35,000. Finally, Merkkuri Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the first quarter worth $43,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on HCA shares. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Leerink Partners restated an "outperform" rating and issued a $492.00 target price on shares of HCA Healthcare in a research note on Friday, September 18th. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Robert W. Baird decreased their price target on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a research note on Monday, July 27th. Finally, TD Cowen increased their target price on shares of HCA Healthcare from $431.00 to $460.00 and gave the stock a "buy" rating in a report on Monday. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $467.61.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $458.39 on Friday. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The company has a market cap of $99.24 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 1.58 and a beta of 1.10. The firm has a 50 day simple moving average of $426.39 and a 200 day simple moving average of $419.27.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period in the previous year, the company earned $6.84 EPS. The firm's revenue was up 8.7% on a year-over-year basis. On average, equities analysts predict that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 16th. HCA Healthcare's dividend payout ratio is presently 10.45%.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.